These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9682036)

  • 1. Transcriptional activation through the vitamin D receptor in osteoblasts.
    Kraichely DM; MacDonald PN
    Front Biosci; 1998 Aug; 3():d821-33. PubMed ID: 9682036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S; Shevde NK; Pike JW
    J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
    J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes.
    Staal A; van Wijnen AJ; Birkenhäger JC; Pols HA; Prahl J; DeLuca H; Gaub MP; Lian JB; Stein GS; van Leeuwen JP; Stein JL
    Mol Endocrinol; 1996 Nov; 10(11):1444-56. PubMed ID: 8923469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
    Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
    Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor.
    Thompson PD; Hsieh JC; Whitfield GK; Haussler CA; Jurutka PW; Galligan MA; Tillman JB; Spindler SR; Haussler MR
    J Cell Biochem; 1999 Dec; 75(3):462-80. PubMed ID: 10536369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast.
    Kephart DD; Walfish PG; DeLuca H; Butt TR
    Mol Endocrinol; 1996 Apr; 10(4):408-19. PubMed ID: 8721985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the 1,25-dihydroxyvitamin D3-induced increase in vitamin D receptor (VDR) levels and binding of VDR-retinoid X receptor (RXR) to a direct repeat (DR)-3 type response element by an RXR-specific ligand in human keratinocyte cultures.
    Jensen TJ; Henriksen LO; Sølvsten H; Kragballe K
    Biochem Pharmacol; 1998 Mar; 55(6):767-73. PubMed ID: 9586948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.
    Bettoun DJ; Burris TP; Houck KA; Buck DW; Stayrook KR; Khalifa B; Lu J; Chin WW; Nagpal S
    Mol Endocrinol; 2003 Nov; 17(11):2320-8. PubMed ID: 12893883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic actions of 1,25-dihydroxyvitamin D3.
    Whitfield GK; Hsieh JC; Jurutka PW; Selznick SH; Haussler CA; MacDonald PN; Haussler MR
    J Nutr; 1995 Jun; 125(6 Suppl):1690S-1694S. PubMed ID: 7782928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hairless modulates ligand-dependent activation of the vitamin D receptor-retinoid X receptor heterodimer.
    Chuma M; Endo-Umeda K; Shimba S; Yamada S; Makishima M
    Biol Pharm Bull; 2012; 35(4):582-7. PubMed ID: 22466564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salt concentration determines 1,25-dihydroxyvitamin D3 dependency of vitamin D receptor-retinoid X receptor--vitamin D-responsive element complex formation.
    Kimmel-Jehan C; Jehan F; DeLuca HF
    Arch Biochem Biophys; 1997 May; 341(1):75-80. PubMed ID: 9143355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
    Zella LA; Kim S; Shevde NK; Pike JW
    Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activity of a fluorinated vitamin D analog on VDR-RXR-mediated gene expression.
    Sasaki H; Harada H; Handa Y; Morino H; Suzawa M; Shimpo E; Katsumata T; Masuhiro Y; Matsuda K; Ebihara K
    Biochemistry; 1995 Jan; 34(1):370-7. PubMed ID: 7819220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3.
    Christakos S; Raval-Pandya M; Wernyj RP; Yang W
    Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):361-71. PubMed ID: 8687373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist-triggered modulation of the activated and silent state of the vitamin D(3) receptor by interaction with co-repressors and co-activators.
    Herdick M; Carlberg C
    J Mol Biol; 2000 Dec; 304(5):793-801. PubMed ID: 11124027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts.
    Schedlich LJ; Muthukaruppan A; O'Han MK; Baxter RC
    Mol Endocrinol; 2007 Oct; 21(10):2378-90. PubMed ID: 17595320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs.
    Liu Y; Shen Q; Malloy PJ; Soliman E; Peng X; Kim S; Pike JW; Feldman D; Christakos S
    J Bone Miner Res; 2005 Sep; 20(9):1680-91. PubMed ID: 16059639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.